A detailed history of Handelsbanken Fonder Ab transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 32,800 shares of MDGL stock, worth $10.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
32,800
Previous 32,500 0.92%
Holding current value
$10.6 Million
Previous $6.9 Million 46.74%
% of portfolio
0.04%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$202.45 - $354.85 $60,735 - $106,455
300 Added 0.92%
32,800 $10.1 Million
Q3 2024

Oct 04, 2024

BUY
$212.22 - $292.96 $190,998 - $263,664
900 Added 2.85%
32,500 $6.9 Million
Q2 2024

Aug 05, 2024

BUY
$193.33 - $291.99 $1.8 Million - $2.72 Million
9,300 Added 41.7%
31,600 $8.85 Million
Q1 2024

May 13, 2024

BUY
$171.37 - $283.23 $3.26 Million - $5.38 Million
19,000 Added 575.76%
22,300 $5.96 Million
Q4 2023

Feb 01, 2024

BUY
$120.4 - $237.13 $60,200 - $118,565
500 Added 17.86%
3,300 $764,000
Q2 2023

Aug 02, 2023

SELL
$203.88 - $312.0 $203,880 - $312,000
-1,000 Reduced 26.32%
2,800 $647,000
Q4 2021

Feb 08, 2022

BUY
$72.34 - $95.09 $79,574 - $104,599
1,100 Added 40.74%
3,800 $322,000
Q2 2021

Aug 03, 2021

BUY
$97.2 - $137.59 $29,160 - $41,277
300 Added 12.5%
2,700 $263,000
Q4 2020

Feb 11, 2021

BUY
$110.06 - $133.7 $264,144 - $320,880
2,400 New
2,400 $267,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.52B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.